IN
NASDAQ · INCR
InterCure Ltd.
Healthcare · Drug Manufacturers - Specialty & Generic
$5.17
Up+$0.14 (+2.78%)
Updated Oct 11, 2026, 10:56 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 67.8M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $0.72 – $6.10
- Volume
- 516.73
- Avg. volume
- 58.85K
Price performance · INCR
INCR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
INCR closed at $5.17 after 20 trading sessions, down 2.27% for the selected period.
- Last close
- $5.17
- Period change
- -2.27%
- Period low
- $5.03
- Period high
- $5.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $5.17 | $5.17 | $5.17 | $5.17 | 516.73 |
| Oct 8, 2026 | $5.10 | $5.1156 | $5.02 | $5.03 | 3.26K |
| Oct 7, 2026 | $5.32 | $5.335 | $5.13 | $5.13 | 7.77K |
| Oct 6, 2026 | $5.30 | $5.32 | $5.30 | $5.32 | 2.62K |
| Oct 5, 2026 | $5.45 | $5.45 | $5.45 | $5.45 | 1.49K |
| Oct 2, 2026 | $5.3836 | $5.42 | $5.3801 | $5.42 | 2.76K |
| Oct 1, 2026 | $5.43 | $5.48 | $5.37 | $5.37 | 2.01K |
| Sep 30, 2026 | $5.37 | $5.38 | $5.23 | $5.272 | 3.6K |
| Sep 29, 2026 | $5.10 | $5.33 | $5.10 | $5.23 | 2.27K |
| Sep 28, 2026 | $5.01 | $5.10 | $5.01 | $5.09 | 2.08K |
| Sep 25, 2026 | $5.10 | $5.26 | $5.02 | $5.21 | 8.86K |
| Sep 24, 2026 | $5.42 | $5.42 | $5.11 | $5.26 | 2.45K |
| Sep 23, 2026 | $5.38 | $5.47 | $5.25 | $5.47 | 5.25K |
| Sep 22, 2026 | $5.32 | $5.6799 | $5.28 | $5.39 | 21.69K |
| Sep 21, 2026 | $5.245 | $5.245 | $5.245 | $5.245 | 493 |
| Sep 18, 2026 | $5.35 | $5.35 | $5.30 | $5.31 | 3.75K |
| Sep 17, 2026 | $5.315 | $5.315 | $5.24 | $5.31 | 1.23K |
| Sep 16, 2026 | $5.21 | $5.36 | $5.21 | $5.31 | 2.53K |
| Sep 15, 2026 | $5.1808 | $5.1808 | $5.13 | $5.13 | 2.32K |
| Sep 14, 2026 | $5.12 | $5.32 | $5.12 | $5.29 | 2.87K |
Latest INCR news
The latest Smart Investors Daily articles mentioning INCR.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…
